Medicxi Ventures Management (Jersey) Ltd — 13F Holdings & Portfolio
CIK 1715579 · latest 13F-HR filed 2026-04-21
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$981.8M
Long-equity book
4
Distinct positions
2026-03-31
Filed 2026-04-21
+0 / −1 / ↑2 / ↓2
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- CENTESSA PHARMACEUTICALS PLC$293.7M +58.8%
- AURA BIOSCIENCES INC$3.8M +22.8%
Top Trims
- PHATHOM PHARMACEUTICALS INC-$40.9M -33.0%
- NEWAMSTERDAM PHARMA COMPANY-$15.1M -15.0%
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | CENTESSA PHARMACEUTICALS PLC | CNTA | 152309100 | $792.9M | 80.76% | 19,963,157 | SH |
| 2 | NEWAMSTERDAM PHARMA COMPANY | NAMS | N62509109 | $85.6M | 8.72% | 2,674,182 | SH |
| 3 | PHATHOM PHARMACEUTICALS INC | PHAT | 71722W107 | $82.9M | 8.45% | 7,464,572 | SH |
| 4 | AURA BIOSCIENCES INC | AURA | 05153U107 | $20.3M | 2.07% | 3,039,892 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-04-21 | $981.8M | 4 | 0001193125-26-166701 |
| 2025-12-31 | 2026-01-23 | $835.0M | 5 | 0001193125-26-020931 |